WealthShield Partners’s Bausch Health BHC Stock Holding History

WealthShield Partners’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-500	Closed	-$16K	–	800
2021 Q1	$16K	Buy	+500	New	+$14.7K	﹤0.01%	701

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

WealthShield Partners's BHC Position: Q2 2021 in Review

WealthShield Partners sold out of Bausch Health (BHC) in Q2 2021, closing a stake of 500 shares — an estimated $16K sold.

WealthShield Partners first reported a position in BHC in Q1 2021 and held it in 1 quarter. The position peaked at $16K in Q1 2021. 357 funds tracked by Wall St. Rank hold BHC as of Q2 2021.

WealthShield Partners reported no remaining Bausch Health position as of Q2 2021 after selling out during the quarter.
WealthShield Partners sold 500 Bausch Health shares in Q2 2021, an estimated $16K.
WealthShield Partners first reported a position in Bausch Health in Q1 2021 and held it in 1 quarter.
WealthShield Partners's Bausch Health position peaked at $16K in Q1 2021.
357 funds tracked by Wall St. Rank held Bausch Health as of Q2 2021.

Based on WealthShield Partners's 13F filing for Q2 2021, filed 6 Aug 2021.